Journament

Keyword Connections - animal models Keywords

Connection Type	Connection
Journals	cns & neurological disorders drug targets Environment international journal of clinical medicine food and chemical toxicology : an international journal published for the british industrial biological research association molecular & cellular proteomics : mcp Hormones and behavior Vaccine current protocols in neuroscience addiction biology
Research Groups	No Research Group Connected
Bibliographies	[1] Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Strategies for In Vivo Administration: Part-II. [2] Overview of Transgenic Mouse Models for Alzheimer's Disease. [3] Proteomic Analysis of Baboon Cerebral Artery Reveals Potential Pathways of Damage by Prenatal Alcohol Exposure. [4] Sexual behavior in rodents: Where do we go from here? [5] The role of HINT1 protein in morphine addiction: An animal model-based study. [6] Phthalate exposure and allergic diseases: Review of epidemiological and experimental evidence. [7] pitfalls in the assessment of murine atherosclerosis [8] mouse models in arrhythmogenic right ventricular cardiomyopathy [9] selective serotonin reuptake inhibitor (ssri) antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved [10] metallic nanoparticles: general research approaches to immunological characterization [11] deep brain stimulation as a tool for improving cognitive functioning in alzheimer’s dementia: a systematic review [12] an objective approach for burkholderia pseudomallei strain selection as challenge material for medical countermeasures efficacy testing [13] can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin? [14] dwi and complex brain network analysis predicts vascular cognitive impairment in spontaneous hypertensive rats undergoing executive function tests [15] interaction of genotype and environment: effect of strain and housing condition on cognitive behaviour in rodent models of schizophrenia [16] the changes of peripheral nerve microstructure after surgical manipulation – experiment on rat model [17] explosive blast neuropathology and seizures [18] development of the central nervous system in guinea pig (cavia porcellus, rodentia, caviidae) [19] antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants [20] imaging axonal degeneration and repair in pre-clinical animal models of multiple sclerosis [21] the role of insulin-like growth factor-i in the physiopathology of hearing [22] modelling alzheimer’s disease: from past to future [23] is 21st century neuroscience too focussed on the rat/mouse model of brain function and dysfunction? [24] the addicted brain. a comment on: addiction is not a brain disease (and it matters) by neil levy. [25] preclinical to clinical translation of studies of transcranial direct-current stimulation in the treatment of epilepsy: a systematic review [26] cancer preventive activities of tea catechins [27] helicobacter pylori: a brief history of a still lacking vaccine [28] decanalization mediating gene-environment interactions in schizophrenia and other psychiatric disorders with neurodevelopmental etiology [29] systematic review of human and animal studies examining the efficacy and safety of n-acetylcysteine (nac) and n-acetylcysteine amide (naca) in traumatic brain injury: impact on neurofunctional outcome and biomarkers of oxidative stress and inflammation [30] Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus [31] What’s not in the news headlines or titles of Alzheimer disease articles? #InMice [32] Tendon regeneration deserves better: focused review on models, artificial intelligence and 3D bioprinting approaches. [33] Antinociceptive potential of viscosine isolated form Dodonaea viscosa in animal models [34] Advance of sporadic Alzheimer's disease animal models. [35] Correction: Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma (Cell Death Discovery, (2019), 5, 1, (112), 10.1038/s41420-019-0194-2) [36] Workshop report: Experimental animal models for universal influenza vaccines. [37] Animal Models in Forensic Science Research: Justified Use or Ethical Exploitation? [38] Current small animal models for LASV hearing loss. [39] Magnetite nanoparticles effects on adverse responses of aquatic and terrestrial animal models [40] Animal Models in the Assessment of Antimicrobial Agents: What should We Expect of Them? [41] Newly developed mastication activity reduction procedure rapidly induces abnormal atrophic change of the mandibular condyle in young and elder experimental animal models. [42] Effects on goal directed behavior and habit in two animal models of parkinson's disease. [43] Noise-induced hearing loss and its prevention: Integration of data from animal models and human clinical trials [44] Regulation of aggressive behaviors by nicotinic acetylcholine receptors: Animal models, human genetics, and clinical studies [45] Recent Developments of Hydrazide/Hydrazone Derivatives and Their Analogs as Anticonvulsant Agents in Animal Models [46] Tackling mitochondrial diversity in brain function: from animal models to human brain organoids. [47] Implantable Therapeutic Reservoir Systems for Diverse Clinical Applications in Large Animal Models. [48] Modeling heart failure in animal models for novel drug discovery and development [49] Animal models of hyperfunctioning parathyroid diseases for drug development [50] Cytomegalovirus antivirals and development of improved animal models [51] What Animal Models Can Teach Us About the Pathogenesis of Tuberculosis in Humans [52] Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome [53] Autism spectrum disorder: neuropathology and animal models [54] contributions and complexities from the use of in-vivo animal models to improve understanding of human neuroimaging signals. [55] rho gtpase regulators and effectors in autism spectrum disorders: animal models and insights for therapeutics [56] central role of the gut epithelial barrier in pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics [57] neurotoxin-induced animal models of parkinson disease: pathogenic mechanism and assessment [58] animal models for alzheimer's disease and frontotemporal dementia: a perspective [59] successful therapies for alzheimer’s disease: why so many in animal models and none in humans? [60] brain in flames – animal models of psychosis: utility and limitations [61] effect of xanthone derivatives on animal models of depression [62] Implications of phytochemicals as disease-modifying agents against Huntington's disease (HD): Bioactivity, animal models and transgenics, synergism and structure–activity studies [63] understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models [64] transcranial direct current stimulation for memory enhancement: from clinical research to animal models [65] the brain decade in debate: ii. panic or anxiety? from animal models to a neurobiological basis [66] elevated mazes as animal models of anxiety: effects of serotonergic agents [67] choline and cystine deficient diets in animal models with hepatocellular injury: evaluation of oxidative stress and expression of rage, tnf-α, and il-1β [68] cancer immunotherapy: historical perspective of a clinical revolution and emerging preclinical animal models [69] a systematic review of the anxiolytic-like effects of essential oils in animal models [70] the glyt1 inhibitor bitopertin ameliorates allodynia and hyperalgesia in animal models of neuropathic and inflammatory pain [71] effects of antipsychotics on dentate gyrus stem cell proliferation and survival in animal models: a critical update [72] animal models of diabetes and metabolic disease 2014 [73] animal models of polymicrobial pneumonia [74] neuropathology and animal models of autism: genetic and environmental factors [75] ocular manifestations of alzheimer’s disease in animal models [76] imaging axonal degeneration and repair in pre-clinical animal models of multiple sclerosis [77] non-mhc risk alleles in rheumatoid arthritis and in the syntenic chromosome regions of corresponding animal models [78] any variation existing in pathways inducing hyperlipidemia in experimental animal models and in real humans may cause difference in treatment success [79] limitations of animal models of parkinson's disease [80] various techniques for the evaluation of anti arthritic activity in animal models [81] comment on successful therapies for alzheimer’s disease: why so many in animal models and none in humans? [82] host pathogen relations: exploring animal models for fungal pathogens [83] the antidepressant-like effect of mentha spicata essential oil in animal models of depression in male mice [84] what we are learning on htlv-1 pathogenesisfrom animal models [85] Do Animal Models of Polycystic Ovary Syndrome Help to Understand Its Pathogenesis and Management? Yes, but Their Limitations Should be Recognized [86] Animal Models for the Study of Infant Botulism [87] Phytochemistry, In-vitro antioxidant, Microbicidal, Anti-ulcerogenic and Biosafety Potential of Emilia coccinea Aqueous Extract in Animal models. [88] The Phytochemistry, In-vitro antioxidant, Microbicidal, Anti-ulcerogenic and Biosafety Potential of Emilia coccinea Aqueous Extract in Animal models.